Publications by authors named "Jenne Ingrassia"

Fibroelastolytic papulosis (FEP) is an acquired cutaneous disorder of elastin that encompasses both white fibrous papulosis of the neck (WFPN) and pseudoxanthoma elasticum (PXE)-like papillary dermal elastolysis (PDE). Although FEP is a benign acquired disorder, it shares overlapping clinical features with pseudoxanthoma elasticum (PXE), a genetic disorder with systemic manifestations. We report two cases of FEP, including the WFPN and PXE-like PDE variants, in elderly women.

View Article and Find Full Text PDF
Article Synopsis
  • JAK inhibitors are effective for treating certain skin conditions but carry a FDA warning due to potential risks, including cardiovascular events and infections, based on data primarily from rheumatoid arthritis patients.
  • The study aimed to assess the risks associated with JAK inhibitors specifically in patients with dermatologic conditions, focusing on mortality and major adverse events.
  • Data from phase 3 clinical trials were analyzed using systematic review methodologies to evaluate the safety of these treatments in dermatology, with results derived from 35 randomized trials.
View Article and Find Full Text PDF

Background: Survival outcomes in acral lentiginous melanoma (ALM) are worse than for cutaneous melanoma. Diagnostic delays are believed to contribute to worse outcomes in ALM, including advanced-stage disease at initial presentation. Acral lentiginous melanoma, especially in its early stages, may be difficult to discern from benign pigmented acral lesions.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a systemic inflammatory disorder that characteristically affects the joints. RA has extra-articular manifestations that can impact multiple organ systems including the heart, lungs, eyes, skin, and brain. Cardiovascular involvement is a leading cause of mortality in RA.

View Article and Find Full Text PDF